Our facilities

To support stem cell research, MCRI has established state-of-the-art facilities including an iPSC Derivation and Gene Editing Facility which annually services internal and external researchers across the world.

MCRI has also recently established a Stem Cell Disease Modelling & Drug Screening Facility to provide high content screening capacity for 3D organoids, as well as the development of significant expertise in transcriptomics and bioinformatics.

Find out more: 

• iPSC Derivation and Gene Editing Facility
• Stem Cell Based Drug Disovery Facility
• Transcriptomics and bioinformatics